Cambria Investment Management’s SPDR Gold Trust GLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.16M Buy
+2,701
New +$1.21M 0.06% 208
2019
Q4
Sell
-67,281
Closed -$9.34M 199
2019
Q3
$9.34M Sell
67,281
-6,779
-9% -$942K 1.4% 9
2019
Q2
$9.87M Buy
74,060
+542
+0.7% +$67K 1.52% 7
2019
Q1
$8.97M Buy
73,518
+507
+0.7% +$62.5K 1.39% 6
2018
Q4
$8.85M Sell
73,011
-5,421
-7% -$630K 1.5% 8
2018
Q3
$8.84M Sell
78,432
-1,833
-2% -$210K 1.3% 8
2018
Q2
$9.44M Buy
80,265
+187
+0.2% +$23.2K 1.4% 7
2018
Q1
$10.1M Sell
80,078
-27,846
-26% -$3.51M 1.46% 7
2017
Q4
$13.3M Buy
107,924
+1,040
+1% +$126K 1.86% 5
2017
Q3
$13M Sell
106,884
-1,063
-1% -$129K 2% 5
2017
Q2
$12.7M Buy
+107,947
New +$12.9M 2.74% 2

Other funds holding GLD

Cambria Investment Management's GLD Position: Q1 2026 in Review

Cambria Investment Management opened a new position in SPDR Gold Trust (GLD) in Q1 2026: 2,701 shares worth $1.16M. The stake represents 0.06% of the portfolio and ranks #208 among its holdings. This is a return to the name: Cambria Investment Management previously reported a position in GLD as recently as Q3 2019.

Cambria Investment Management first reported a position in GLD in Q2 2017 and has held it in 11 quarters since. The position peaked at $13.3M in Q4 2017. 3,149 funds tracked by Wall St. Rank hold GLD as of Q1 2026.

  • Cambria Investment Management held 2,701 shares of SPDR Gold Trust worth $1.16M as of Q1 2026.
  • SPDR Gold Trust was a new Cambria Investment Management position in Q1 2026.
  • SPDR Gold Trust made up 0.06% of Cambria Investment Management's portfolio in Q1 2026, its #208 holding.
  • Cambria Investment Management first reported a position in SPDR Gold Trust in Q2 2017 and has held it in 11 quarters since.
  • Cambria Investment Management's SPDR Gold Trust position peaked at $13.3M in Q4 2017.
  • 3,149 funds tracked by Wall St. Rank held SPDR Gold Trust as of Q1 2026.

Based on Cambria Investment Management's 13F filing for Q1 2026, filed 15 May 2026.